
Steven B. Wong
Examiner (ID: 12169, Phone: (571)272-4416 , Office: P/3711 )
| Most Active Art Unit | 3711 |
| Art Unit(s) | 2899, 1304, 3304, 3711 |
| Total Applications | 2939 |
| Issued Applications | 1770 |
| Pending Applications | 164 |
| Abandoned Applications | 1020 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7207108
[patent_doc_number] => 20050043336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Quinazoline derivatives as antitumor agents'
[patent_app_type] => utility
[patent_app_number] => 10/494137
[patent_app_country] => US
[patent_app_date] => 2002-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71621
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043336.pdf
[firstpage_image] =>[orig_patent_app_number] => 10494137
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/494137 | Quinazoline derivatives as antitumor agents | Oct 30, 2002 | Abandoned |
Array
(
[id] => 7216726
[patent_doc_number] => 20050054662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Quinazoline derivatives as antitumor agents'
[patent_app_type] => utility
[patent_app_number] => 10/494388
[patent_app_country] => US
[patent_app_date] => 2002-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89003
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054662.pdf
[firstpage_image] =>[orig_patent_app_number] => 10494388
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/494388 | Quinazoline derivatives as antitumor agents | Oct 30, 2002 | Abandoned |
Array
(
[id] => 7380059
[patent_doc_number] => 20040220404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Pyrimidinones as melanin concentrating hormone receptor 1'
[patent_app_type] => new
[patent_app_number] => 10/492641
[patent_app_country] => US
[patent_app_date] => 2004-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31406
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220404.pdf
[firstpage_image] =>[orig_patent_app_number] => 10492641
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/492641 | Pyrimidinones as melanin concentrating hormone receptor 1 | Oct 14, 2002 | Issued |
Array
(
[id] => 6651611
[patent_doc_number] => 20030105087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => ' New polycyclic azaindole compounds'
[patent_app_type] => new
[patent_app_number] => 10/267303
[patent_app_country] => US
[patent_app_date] => 2002-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14715
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20030105087.pdf
[firstpage_image] =>[orig_patent_app_number] => 10267303
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/267303 | Polycyclic azaindole compounds | Oct 8, 2002 | Issued |
Array
(
[id] => 185604
[patent_doc_number] => 07645878
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-12
[patent_title] => 'Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof'
[patent_app_type] => utility
[patent_app_number] => 10/252369
[patent_app_country] => US
[patent_app_date] => 2002-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13561
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/645/07645878.pdf
[firstpage_image] =>[orig_patent_app_number] => 10252369
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/252369 | Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof | Sep 23, 2002 | Issued |
Array
(
[id] => 6797823
[patent_doc_number] => 20030176697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Method for preparing crambescidin core acid intermediates and their use for preparing crambescidin alkaloid analogs as therapeutic agents'
[patent_app_type] => new
[patent_app_number] => 10/255994
[patent_app_country] => US
[patent_app_date] => 2002-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11827
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176697.pdf
[firstpage_image] =>[orig_patent_app_number] => 10255994
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/255994 | Method for preparing crambescidin core acid intermediates and their use for preparing crambescidin alkaloid analogs as therapeutic agents | Sep 23, 2002 | Abandoned |
Array
(
[id] => 6852105
[patent_doc_number] => 20030144308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Fructose 1,6-bisphosphatase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/251073
[patent_app_country] => US
[patent_app_date] => 2002-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19072
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20030144308.pdf
[firstpage_image] =>[orig_patent_app_number] => 10251073
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/251073 | Fructose 1,6-bisphosphatase inhibitors | Sep 19, 2002 | Abandoned |
Array
(
[id] => 6835249
[patent_doc_number] => 20030162795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'Thienopyrimidine and thienopyridine derivatives useful as anticancer agents'
[patent_app_type] => new
[patent_app_number] => 10/244324
[patent_app_country] => US
[patent_app_date] => 2002-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35409
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20030162795.pdf
[firstpage_image] =>[orig_patent_app_number] => 10244324
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/244324 | Thienopyrimidine and thienopyridine derivatives useful as anticancer agents | Sep 15, 2002 | Abandoned |
Array
(
[id] => 7389031
[patent_doc_number] => 20040030129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'NF-kappaB inhibitor comprising phenylmethyl benzoquinone as an active ingredient'
[patent_app_type] => new
[patent_app_number] => 10/243737
[patent_app_country] => US
[patent_app_date] => 2002-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 31797
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20040030129.pdf
[firstpage_image] =>[orig_patent_app_number] => 10243737
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/243737 | NF-kappaB inhibitor comprising phenylmethyl benzoquinone as an active ingredient | Sep 15, 2002 | Abandoned |
Array
(
[id] => 6684021
[patent_doc_number] => 20030119885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => ' CCR-3 receptor antagonists'
[patent_app_type] => new
[patent_app_number] => 10/242610
[patent_app_country] => US
[patent_app_date] => 2002-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10904
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119885.pdf
[firstpage_image] =>[orig_patent_app_number] => 10242610
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/242610 | CCR-3 receptor antagonists | Sep 11, 2002 | Issued |
Array
(
[id] => 6683970
[patent_doc_number] => 20030119834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Compositions and methods of treatment of cancer'
[patent_app_type] => new
[patent_app_number] => 10/236863
[patent_app_country] => US
[patent_app_date] => 2002-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10060
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119834.pdf
[firstpage_image] =>[orig_patent_app_number] => 10236863
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/236863 | Compositions and methods of treatment of cancer | Sep 4, 2002 | Abandoned |
Array
(
[id] => 1178187
[patent_doc_number] => 06743801
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-01
[patent_title] => '1,2,3,6-tetrahydropyrimidine-2-one compositions and therapeutic methods therewith for pain and inflammation'
[patent_app_type] => B2
[patent_app_number] => 10/232798
[patent_app_country] => US
[patent_app_date] => 2002-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7511
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/743/06743801.pdf
[firstpage_image] =>[orig_patent_app_number] => 10232798
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/232798 | 1,2,3,6-tetrahydropyrimidine-2-one compositions and therapeutic methods therewith for pain and inflammation | Aug 28, 2002 | Issued |
Array
(
[id] => 6745706
[patent_doc_number] => 20030022889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Method for providing neuro-protective effects'
[patent_app_type] => new
[patent_app_number] => 10/228618
[patent_app_country] => US
[patent_app_date] => 2002-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4365
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022889.pdf
[firstpage_image] =>[orig_patent_app_number] => 10228618
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/228618 | Method for providing neuro-protective effects | Aug 26, 2002 | Abandoned |
Array
(
[id] => 6653250
[patent_doc_number] => 20030008866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-09
[patent_title] => 'Bicyclic inhibitors of glycogen synthase kinase 3'
[patent_app_type] => new
[patent_app_number] => 10/228621
[patent_app_country] => US
[patent_app_date] => 2002-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16236
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20030008866.pdf
[firstpage_image] =>[orig_patent_app_number] => 10228621
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/228621 | Bicyclic inhibitors of glycogen synthase kinase 3 | Aug 25, 2002 | Abandoned |
Array
(
[id] => 910424
[patent_doc_number] => 07329665
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-12
[patent_title] => 'Quinazolinone derivative'
[patent_app_type] => utility
[patent_app_number] => 10/485865
[patent_app_country] => US
[patent_app_date] => 2002-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4398
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/329/07329665.pdf
[firstpage_image] =>[orig_patent_app_number] => 10485865
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/485865 | Quinazolinone derivative | Aug 1, 2002 | Issued |
| 10/129017 | Isoquinoline and quinazoline derivatives for the treatment of cns disorders | Jul 31, 2002 | Abandoned |
Array
(
[id] => 1102736
[patent_doc_number] => 06811357
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-02
[patent_title] => 'Retaining wall assembly'
[patent_app_type] => B1
[patent_app_number] => 10/207751
[patent_app_country] => US
[patent_app_date] => 2002-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 1562
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/811/06811357.pdf
[firstpage_image] =>[orig_patent_app_number] => 10207751
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/207751 | Retaining wall assembly | Jul 29, 2002 | Issued |
Array
(
[id] => 6689080
[patent_doc_number] => 20030032805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Process for the preparation of high purity pemirolast'
[patent_app_type] => new
[patent_app_number] => 10/196260
[patent_app_country] => US
[patent_app_date] => 2002-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 706
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20030032805.pdf
[firstpage_image] =>[orig_patent_app_number] => 10196260
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/196260 | Process for the preparation of high purity Pemirolast | Jul 16, 2002 | Issued |
| 10/129035 | Isoquinoline and quinazoline derivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity | Jul 15, 2002 | Abandoned |
Array
(
[id] => 6801641
[patent_doc_number] => 20030096806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Arylphenyl-substituted cyclic ketoenols'
[patent_app_type] => new
[patent_app_number] => 10/192361
[patent_app_country] => US
[patent_app_date] => 2002-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31918
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20030096806.pdf
[firstpage_image] =>[orig_patent_app_number] => 10192361
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/192361 | Arylphenyl-substituted cyclic ketoenols | Jul 9, 2002 | Abandoned |